A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

NCT07730021 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

392

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Solid Tumors

Interventions

DRUG: ASP388B
DRUG: Pembrolizumab
DRUG: Carboplatin
DRUG: Oxaliplatin
DRUG: 5-fluorouracil

Sponsor

Astellas Pharma Global Development, Inc.